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Abstract
Background: Van der Woude syndrome (MIM: 119300, VWS) is a dominantly inherited and the most common
orofacial clefting syndrome; it accounts for ~2 % of all cleft lip and palate cases. Intellectual disability (ID) is
characterized by significant limitations, both in intellectual functioning (cognitive deficit) and in adaptive behavior
as expressed in conceptual, social and practical adaptive skills. Karyotyping has been the first standard test for the
detection of genetic imbalance in patients with ID for more than 35 years. Advances in genetic diagnosis have laid
chromosomal microarrays (CMA) as a new standard and first first-line test for diagnosis of patients with ID, as well
as other conditions, such as autism spectrum disorders or multiple congenital anomalies.
Case Presentation: The present case was initially studied due to unexplained cognitive deficit. Physical
examination at the age of 18 years revealed cleft palate, lower lip pits and hypodontia, accompanied with other
dysmorphic features and absence of speech. Brain MRI uncovered significantly reduced overall volume of gray
matter and cortical gyrification. Banding cytogenetics revealed an indistinct intrachromosomal rearrangement in the
long arm of one chromosome 1, and subsequent microarray analyses identified a 5.56 Mb deletion in 1q32.1-
1q32.3, encompassing 52 genes; included were the entire IRF6 gene (whose mutations/deletions underlay VWS) and
SRGAP2, a gene with an important role in neuronal migration during development of cerebral cortex. Besides, a
duplication in 3q26.32 (1.9 Mb in size) comprising TBL1XR1 gene was identified. Multicolor banding for
chromosome 1 and molecular cytogenetics applying a battery of locus-specific probes covering 1q32.1 to 1q44
characterized a four breakpoint-insertional-rearrangement-event, resulting in 1q32.1-1q32.3 deletion.
Conclusions: Considering that the human-specific three-fold segmental duplication of SRGAP2 gene evolutionary
corresponds to the beginning of neocortical expansion, we hypothesize that aberrations in SRGAP2 are strong
candidates underlying specific brain abnormalities, namely reduced volume of grey matter and reduced gyrification.
Background
Van der Woude syndrome (MIM: 119300, VWS) is a
dominantly inherited and the most common orofacial
clefting syndrome; it accounts for ~2 % of all cleft lip
and palate cases [1]. A clinical synopsis for VWS pre-
dominantly includes mouth and teeth abnormalities
(lower lip pits, cleft lip and/or palate and hypodontia).
In addition, abnormalities of limb, skin, nails and genital
and/or hearing loss could be present [2]. 1q32-41
chromosomal location was mapped as being critical for
VWS in 1987, when a patient with an interstitial deletion
of chromosome 1q32-41 was reported [3]. Only in 2002,
by direct sequencing, mutations in the IRF6 gene were
detected and linked to VWS and popliteal pterygium
syndrome [4]. About 70 % of VWS causal mutations
occur in IRF6 gene [5], however, in less than 2 % of indi-
viduals with VWS entire IRF6 gene is deleted [6].
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Nowadays it is worldwide recognized that IQ test
score of 70–75 and lower, indicates a limitation in intel-
lectual functioning or cognitive deficit. Intellectual dis-
ability (ID) is characterized by significant limitations,
both in intellectual functioning (cognitive deficit) and in
adaptive behavior as expressed in conceptual, social and
practical adaptive skills [7]. ID is divided into five cat-
egories based on IQ (mild, moderate, severe, profound
and unable to classify) [8]. In addition to that, ID can be
grouped into syndromic (patients with one or multiple
additional clinical features) and non-syndromic (i.e. ID
as sole clinical feature). Karyotyping has been the first
standard test for the detection of genetic imbalance in
patients with ID for more than 35 years. Advances in
genetic diagnosis have laid chromosomal microarrays
(CMA) as a new standard and first first-line test for
diagnosis of patients with ID. Cytogenetic and CMA as a
“state-of-the-art” molecular-cytogenetic method are used
in other conditions as well, such as autism spectrum dis-
orders, multiple congenital anomalies and diverse brain
diseases. Genetic findings in children with autistic disor-
ders support conclusion that cytogenetic and molecular-
cytogenetic studies should be considered as compulsory
in terms of detecting possible genetic causes of cognitive
deficit and brain diseases [9, 10].
Case presentation
At the age of 18 years the female patient was studied
due to unexplained cognitive deficit. She was born after
an uneventful pregnancy after 32 weeks of gestation
(birth weight: 2400 g, birth length: 40 cm) as a child of
closely related parents (3rd degree). According to scant
data on her early development, she started to walk at the
age of 2 years and her language development was se-
verely delayed. The girl was born with palathoshisis
which was surgically corrected at the age of 3 years,
when also the encephalopathy, vesicoureteral reflux, ex-
pressive (motor) dysphasia and developmental delay
were diagnosed. At the age of 9 years she still could not
control the sphincters and was diagnosed with moderate
to severe cognitive deficit and undeveloped speech (due
to articulation disorder), and was moved from socially
deprived environment in foster care homes. In addition
to cleft palate as the primary clinical feature, she had
thin lips with bilateral pits, indistinct and short philtrum,
flat midface, narrow palpebral fissures, hypodontia
(missing upper incisor) with irregular dental growth,
acne-prone skin, hirsutism, broad thumbs, and short and
tapering fingers. By the age of 18 years she developed
some limited communication skills, but due to articula-
tion irregularities the speech was rather incomprehen-
sible and reduced to short sentences. Graphomotor
development was delayed; no writing and reading skills
were developed. She was deprived in spatial orientation
and was not able to understand the concept of time.
Materials and methods
Cytogenetics and molecular cytogenetics
This patient was studied within the project approved by
the ethics committee of the School of Medical, Univer-
sity of Zagreb and the institution from which the patient
comes. Peripheral blood was taken with a written in-
formed consent by the institution from which the pa-
tient comes. Banding cytogenetics from peripheral blood
lymphocytes was done according to the standard pro-
cedure. Fluorescence in situ hybridization (FISH) was
done according to standard protocols using multicolor-
banding probe-sets (MCB) and bacterial artificial
chromosome (BACs) probes [9, 10]. All BACs used in
this study are listed in Additional file 1. Genomic DNA
was extracted from whole blood by Puregene DNA Puri-
fication Kit (Gentra Systems, Minneapolis, MN, USA)
following manufactureinstructions. Multiplex ligation
dependent probe amplification (MLPA) analysis was per-
formed according to the manufacturer’s instructions
(MRC-Holland, the Netherlands) using ABI-PRISM
3130XL Genetic Analyzer (Applied Biosystems, Foster
City, USA). MLPA data analysis was done by use of Gen-
eMarker software package (SoftGenetics, USA). Subtelo-
meric MLPA (P036-E2, P070-B2) and microdeletion/
microduplication (P245-B1, P297-B2) probe sets were
used. Arraycomparative genomic hybridization (aCGH)
was performed on Agilent oligonucleotide SurePrint G3
Human Genome microarray 4X180 K (Agilent Tech-
nologies, Santa Clara, CA, USA). The array was proc-
essed following the manufacturer’s recommended
protocol, and a sex-matched non-disease control sample
(Promega, Mannheim, Germany) was used as a refer-
ence. Array results were analyzed using Cytogenomics
software setting ADM2 aberration algorithm. Publicly
available data for spatio-temporal expression profiles in
brain [11] was screened by specially designed algorithm
for all detected genes with aberrant copy number as pre-
viously described [12].
Brain MRI
Magnetic resonance imaging was performed on a 3T
MR device (Magnetom TrioTim, Siemens; Germany),
with 32-channel head coil, using standard set of se-
quences that included sagittal 3D magnetizationprepared
rapid acquisition gradient echo (MPRAGE) sequence
with voxel size 1 mm x 1 mm x 1 mm (TR = 2300 ms;
TE = 3 ms; flip angle = 9 degrees; matrix : 256 x 256).
Volumetric processing of MR images was conducted by
using the CIVET (version 1.1.11) pipeline developed at
Montreal Neurological Institute, Brain Imaging Centre
[13]. This automated pipeline provided tools for
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observer independent corticometric analysis [14–28].
The calculated measurements included volumes of the
grey and white matter tissue, of cerebrospinal fluid, and
gyrification index for both hemispheres. Quantification
of regional cortical thicknessaverages where lobe borders
were determined by sulcal landmarks and detected by
the CIVET pipeline, and regional/lobar cortical volume
and surface area estimates were made for parietal, oc-
cipital, frontal, and temporal lobes, and for isthmus of
cingulate gyrus, parahippocampal and cingulate gyrus,
and insula. The gyrification index is a metric that quan-
tifies the amount of cortex buried within the sulci com-
pared to the amount of surface visible cortex. The
gyrification index was computed by dividing the total
cortical surface area with the area of the convex hull.
Results
Banding cytogenetics revealed an indistinct intrachro-
mosomal rearrangement in the long arm of one chromo-
some 1 (Fig. 1). MLPA analyses with subtelomeric probe
sets (P036 and P070) followed by screening for microde-
letion/microduplication syndromes (P245 and P297)
showed normal results (data not shown). Subsequent
aCGH analysis identified a 5.56 Mb copy number loss in
1q32.1-1q32.3, encompassing 52 genes (one partially de-
leted and 51 completely deleted genes), and a copy number
gain in 3q26.32 (1.9 Mb in size) comprising TBL1XR1
(Fig. 2). 3q26.32 duplication was confirmed by BAC FISH
analyses (Fig. 3). In order to characterize the structural re-
arrangement within 1q, FISH using MCB and a battery of
BACs was applied. A four breakpoint insertional rearrange-
ment was identified, with a karyotype: 46,XX,der(1)(pter- >
q32.1::q42.2- > q44::q32.3- > q42.13::q44- > qter),dup(3)(q26.
32q26.32).arr[hg19]1q32.1q32.3(206,279,995-211,840,280)x
1,3q26.32(176,738,433-176,929,584)x3 (Fig. 4). Heat maps
for genes with enriched expression in human brain:
PLXNA2, SYT14, RCOR3, CD55, KCNH1 and TBL1XR1
are presented and described in Fig. 5, and detailed descrip-
tion of gene function is in Additional file 2. Genes import-
ant for clinical physical phenotype of the patient are listed
in a Table 1.
Visual evaluation of brain MRI exam at the age of 21
showed pineal cyst, 8 × 5 × 8 mm in size, without com-
pressive effect on surrounding structures. Cavum septi
pellucidi and cavum verge were present in medial line.
There was reduced pneumatisation of mastoid cells on
both sides. The rest of the findings were described as
normal. Volumetric analysis revealed overall reduced
volume of gray matter (−2.91 STDEV) and cortical gyri-
fication (gray: −7.27 STDEV; white: −4.79 STDEV; mid:
−8.80 STDEV) (Table 2). Remaining findings of brain
volumetric analysis are described in Additional file 3.
Discussion
Clinical physical presentation - van der Woude syndrome
Here we report a 1q32.1-1q32.3 deletion of 5.56 Mb in a
girl patient presenting a main features of VWS accom-
panied with severe cognitive deficit. Most prominent
VWS phenotypic characteristics in the present case are
well described in the literature and could be assigned to
at least several genes (LAMB3, G0S2, IRF6, RD3, NEK2
and KCNH1) described in Table 2. Haploinsufficiency
score1 for IRF6 gene is extremely low (HI score 2.02 %),
it is therefore most likely that in present case phenotype
characteristics (cleft palate, lower bilateral pits and hypo-
dontia) are consisted with the literature descriptions of
VWS, and are repercussions of IRF6 haploinsufficiency.
Besides, some cases with small deletions in IRF6 gene
were described as well. Three cases with a microdeletion
(0.1–1 Mb in size) were detected by CMA in a large co-
hort of patients with clinical diagnosis of VWS [29, 30].
Mutation in G0S2 and NEK2 genes were associated with
phenotype of VWS [31], but contribution of haploinsuf-
ficiency of these genes in our case is questionable due to
two facts: I) high HI score for booth genes (G0S2 88,45
and NEK2 25,91), and II) NEK2 is only partly deleted.
Mutations in LAMB3 gene causes autosomal recessive
skin disorder with blisters on the skin – Junctional
Epidermolysis (JEB) [31]. In presented case LAMB3 dele-
tion might have unmasked the recessive allele, as the HI
score is high (58.66). Therefore, the phenotype manifesta-
tions restricted to acne-prone skin could represent a very
mild form of Non-Herlitz type of JEB (MIM 226650).
Conformation of Non-Herlitz type of JEB could be done
only by direct sequencing of affected LAMB3 gene. Muta-
tions in KCNH1 gene are responsible for two severe
Fig. 1 GTG-banding. Aberrant banding pattern on chr 1 indicated
by an arrowhead
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phenotypes, Temple-Baraitser syndrome (MIM: 611816)
and Zimmermann-Laband syndrome 1 (MIM: 135500),
respectively; both characterized by similar clinical synop-
ses and severe cognitive deficit (Table 2.). The HI score
for KCNH1 is relatively high (22.53) but in the present
case distinct physical phenotype ((wide mouth, broad
nasal bridge, hirsutism, broad thumbs and short and
tapering fingers) could be due to KCNH1
haploinsufficiency.
Cognitive phenotype2
Research of cognitive function has shown that group of
patients with clinical VWS diagnosis have just a slightly
wider distribution of full-scale IQ (84 to 118) compared
Fig. 2 aCGH analysis. 5.56 Mb copy number loss in 1q32.1-1q32.3 and additional deletion detected in 1p31.1 (26 Kb) and 1q21.1 (202 Kb) regions,
without gene content. Duplication in 3q26.32 (1.9 Mb in size). Genomic coordinates and gen content are written in table (hg38)
Fig. 3 FISH analysis. PR11-484D1 BAC (green signal) confirmed duplication of TBL1XR1 genes on chromosome 3q26.32. The arrow indicates the
aberrant chromosome
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to controls (96 to 123) [32]. The evaluation of brain
morphology in patients with clinical diagnosis of non-
syndromic clefts of the lip and/or palate have pointed to
some brain abnormalities. The most severely affected re-
gion was the left temporal lobe with decreased gray mat-
ter volume [33]. In presented case, brain MRI showed
reduced temporal lobe in all volumetric measurements
(Additional file 3), but this finding alone cannot suffi-
ciently explain a cognitive deficit.
Five cases have been so far reported to have deletions
which included additional genes outside of the IRF6
gene (Fig. 6) [3, 34–37]. First case was microscopically
detected 1q gross deletion (no high resolution mapping)
that most likely extends beyond distal and proximal
breakpoint of our case, so it is difficult to discuss mo-
lecular basis of cognitive phenotype. Additional two
cases were assigned by STR mapping and showed over-
lapping genomic region (CAMK1G on the proximal end
LAMB3, TRAF3IP3, IRG6 and part of SYT14 genes on
the distal end) (Fig. 6). Cases studied with STR mapping
provide only a limited insight into the genome; therefore
the contribution of additional aberrations to the pheno-
type cannot be excluded.
Only two reported cases were studied by high reso-
lution array technique. Tan et al. [37] reported a patient
with de novo 2.3 Mb 1q32.2 microdeletion, presenting
orofacial VWS phenotype. He was otherwise healthy in-
dividual, followed up closely for the last 20 years and
Fig. 4 FISH analyses. 1. MCB1 chromosome profile. Light dashed vertical line presenting chromosome MCB band position. On the left side of the
figure is normal chr1. showing normal banding pattern. Note aberrant banding pattern on the right side. 1q42.3qter insertion in 1q32.2 position
indicated by an arrowhead. Note that a complete MCB band (1q42.3qter) in BIO-Cy5 (yellow) is inserted more proximal to centromere. 2. BAC FISH
analysis. RP5-940 F7 (red) 1q42.3, RP11-391H5 (yellow) 1q42.2, RP11-100E13 (blue) 1q42.12, RP11-286E7 (green) 1q32.3. N – normal chr1, INSERTION
– aberrant chr1. Note: inserted segment (1q42.2q44) has an normal direction. 3. RP11-99 J16 (green) 1q42, RP11-438G15 (blue) 1q41, RP11-534 L20
(red) 1q32.1. Red arrowhead indicating aberrant chr1. 1q32.1q32.3 deletion and 1q42.2q44 insertion (missing red signal and misplaced order of
blue and green signals). N-normal chr1. Del-aberrant chr1. 4. Schematic representation of the detected aberrations. N#1 normal chr; Del#1 aberrant chr.
On the long arm of chromosome 1 there are four break points (1q32.1, 1q32.3, 1q44 1q42.13 – red dotted line on N#1) resulting in a deletion of the
entire 1q32.2 (shown on Del #1). In addition there is a 1q42.2q44 segment insertion (yellow) on the position of the 1q32.2 deletion— leading to more
distal position of 1q32.3-q42.13 (green). Telomeric segment 1q44 (blue) is not affected by this complex rearrangement
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there was no evidence of cognitive deficit [37]. Gene
content shared with our case included PLXNA2 and
SYT14 (Fig. 6). Since there was no evidence of cognitive
deficit in case of Tan et al. [37], we may only discuss the
contribution of PLXNA2 and SYT14 genes to the cogni-
tive phenotype in our case. PLXNA2 mediates signals
from two semaphorins (SEMA3 and SEMA6) and plays
a role in axon guidance (guiding axonal growth cones),
invasive growth and cell migration. Although PLXNA2
HI score is 5.01, the lack of cognitive phenotype in case
reported by Tan et al. could be due to incomplete
penetrance, as knockout mice for SEMA3 and SEMA6
show the neural abnormalities to some extent. It is pos-
sible that plexin-semaphorn diversity and brain “plasti-
city” could prenatally compensate for PLXNA2
haploinsufficiency, meaning that a signal transduction of
SEMA3 and SEMA6 could go via other receptors during
neurodevelopment. SYT14 is expressed prenatally, has HI
score of 18.19, and has a role in prenatal neurotransmis-
sion. In case of Tan et al. [37] distal breakpoint is disrupt-
ing SYT14, so the haploid state might possibly be
sufficient for the normal development. The second case
Fig. 5 Spatio-temporal expression profiles in brain. PLXNA2 shows highest expression pattern in all cortical areas, basal ganglia and thalamus from early to
late fetal period. Even though expression level slightly goes down perinatally, it remains high throughout postnatal time. SYT14 and RCOR3 are highly
expressed in prenatal human brain (cerebral cortex, basal ganglia, thalamus and cerebellum) and it goes slightly down neonatally. TBL1XR1 expression
pattern in brain remains mainly high and stabile throughout lifespan. CD55 expression goes up in perinatal time and remains high throughout postnatal
time and adulthood. KCNH1 shows high expression in postnatal cerebral cortex and basal ganglia. FC-frontal cerebral wall, OFC-orbital prefrontal cortex,
DFC-dorsolateral prefrontal cortex, VFC-ventrolateral prefrontal cortex, MFC-medial prefrontal cortex, M1C-Primary motor cortex, S1C-Primary somatosensory
cortex, IPC-Posterior inferior parietal cortex, A1C-Primary auditory cortex, STC-Superior temporal cortex, ITC-Inferior temporal cortex, V1C-Primary visual
cortex, HIP-Hippocampus, AMY-Amygdala, STR-Striatum, MD-Mediodorsal nucleus of the thalamus, CBC-Cerebellar cortex. Period 3 (Early fetal development,
10 PCW (post-conceptional weeks) < Age <13 PCW), Period 4 (Early mid-fetal development, 13 PCW < Age <16 PCW), Period 5 (Early mid-fetal
development, 16 PCW < Age <19 PCW), Period 6 (Late mid-fetal development, 19 PCW < Age <24 PCW), Period 7 (Late fetal development, 24
PCW < Age <38 PCW), Period 8 (Neonatal and early infancy, birth ≤ Age <6 M (postnatal months), Period 9 (Late infancy, 6 M< Age <12 M),
Period 10 (Early childhood, 1 Y (year) < Age <6 Y), Period 11 (Middle and late childhood, 6 Y< Age <12 Y), Period 12 (Adolescence, 12 Y< Age
<20 Y), Period 13 (Young adulthood, 20 Y< Age <40 Y), Period 14 (Middle adulthood, 40 Y< Age <60 Y), Period 15 (Late adulthood, 60 Y +)
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studied with CMA, was a 22-month-old baby presenting
with a 2.98 Mb deletion in 1q32.2–q32.3 region, who in
addition to VWS, displayed developmental delay and dys-
morphism [36]. KCNH1 and RCOR3 genes were the only
two deleted genes enriched in human brain and over-
lapped with present case (Fig. 6). Mutations in aforemen-
tioned KCNH1 gene are responsible for two
syndromes, the Temple-Baraitser (MIM 611816) and
Zimmermann-Laband (MIM 135500) syndrome 1,
both being developmental disorders characterized by
severe cognitive and physical abnormalities (Table 1.).
RCOR3 gene important for restricting the neural
features to neuron has HI score of 13.05 and is
prenatally expressed. Taking into account the above
mentioned facts, KCNH1 and ROCR3 are good
candidate genes whose haploinsufficiency may be
liable for severe cognitive deficit combined with
dysmorphism.
Table 1 Genes important for clinical phenotype of the patient from OMIM database
Name MIM Chr Phenotype Clinical synopsis
LAMB3 laminin subunit beta 3 150310 1q32.2 mutation:Junctional Epidermolysis
Bullosa, Herlitz Type and Non-Herlitz
Type;Amelogenesis imperfecta, type IA
Junctional Epidermolysis – autosomal recessive skin
disorder in which blisters occur at the level of the
lamina lucida in the skin basement membrane, Herlitz
type is more severe than Non-Herlitz type and often
results in early death;Amelogenesis imperfecta IA is
characterized by enamel that may not develop to
normal thickness
G0S2 G0/G1 switch 2 614447 1q32.2 ?Van der Woude syndrome (VWS) VWS is dominantly inherited developmental disorder
characterized by pits and/or sinuses of the lower lip,
and cleft lip and/or cleft palate (CL/P, CP)
IRF6 interferon regulatory
factor 6
607199 1q32.2 mutation: Van der Woude syndrome;
Popliteal pterygium syndrome 1 (PPS);
Orofacial cleft 6
VWS is dominantly inherited developmental disorder
characterized by pits and/or sinuses of the lower lip,
and cleft lip and/or cleft palate (CL/P, CP);PPS has a
highly variable clinical presentation including
orofacial, cutaneous, musculoskeletal, and genital
anomalies;Orofacial cleft 6 is nonsyndromic cleft lip
with or without cleft palate
RD3 retinal degeneration 3 180040 1q32.2 mutation: Leber congenital
amaurosis 12
early-onset childhood retinal dystrophies
characterized by vision loss, nystagmus, and severe
retinal dysfunction
NEK2 NIMA-related kinase 2 604043 1q32.2 ?retinitis pigmentosa 67; ?Van der
Woude syndrome
hereditary retinal conditions in which degeneration of
rod photoreceptors is more pronounced than that of
cone photoreceptors
KCNH1a potassium channel,
voltage gated eag
related subfamily H,
member 1
603305 1q32.2 Zimmermann-Laband syndrome 1
Temple-Baraitser syndrome
Zimmermann-Laband - rare disorder characterized by
gingival fibromatosis, dysplastic or absent nails,
hypoplasia of the distal phalanges, scoliosis,
hepatosplenomegaly, hirsutism, abnormalities of the
cartilage of the nose and/or ears and developmental
delayTemple-Baraitser syndrome - rare developmental
disorder, severe mental retardation and anomalies of
the first ray of the upper and lower limbs with
absence/hypoplasia of the nails.
aKCNH1 gene is also in group with genes enriched in human brain (see Fig. 5)
Table 2 Volumetric brain MRI analysis
AVER/controls Patient STDEV s
gyrification index gray 3.36 3.03 0.05 −7.27
gyrification index white 3.45 3.26 0.04 −4.79
gyrification index mid 3.29 3.04 0.03 −8.80
cls volumes AVER/controls Patient STDEV s
cerebro-spinal fluid 152,006.03 132,909.60 10,435.97 −1.83
grey matter 700,914.38 533,477.70 57,613.85 −2.91
white matter 527,492.03 525,524.77 58,502.68 −0.03
total volume 1,380,412.44 1,191,912.07 117,247.09 −1.61
Bold numbers and text are pointing to more than 3 standard deviation deference between control and patient measurements
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The main players for cognitive deficit (1q32.1 :SRGAP2
and CD55; 3q26.33 :TBL1XR1)
In comparison to two cases studied by array, our case
has a proximal breakpoint further extended in 1q32.1,
and the deletion covers additional genes including
SRGAP2 and CD55.
SRGAP2 (SLIT-ROBO Rho GTPase activating protein
2, HGNC: 19751). There are four copies of SRGAP2 gene:
the parental SRGAP2A and three duplicates (SRGAP2B,
SRGAP2C and SRGAP2D) [38]. The first duplication event
occurred ~3.4 million years ago when only first 9 (out of
the 22) exons of parental SRGAP2A were duplicated. This
segmental duplication truncated SRGAP2B in its F-BAR
domain, which led to the key functional consequences.
Second segmental duplication occurred ~2.4 million years
ago copying SRGAP2B to SRGAP2C. The most recent seg-
mental duplication happened ~1 million years ago when
segmental duplication of SRGAP2B gave rise to SRGAP2D
(Fig. 7). Human-specific three-fold segmental duplication
of SRGAP2 gene, evolutionary corresponds to the begin-
ning of neocortical expansion in humans [38]. Studies on
SRGAP2 function reveled that it regulates neural migra-
tion and neurite outgrowth and branching, and is
expressed throughout the developing cortex in prolifera-
tive zones (ventricular zone VZ and subventricular zone
SVZ) and in postmitotic zone (cortical plate CP) [39, 40].
Description of SRGAP2 function and summary of research
on loss/gain of function is presented in Table 3. SRGAP2C
inhibits ancestral SRGAP2 function during cortical neural
migration and displays spine morphology phenotype char-
acteristics of SRGAP2 knockdown resulting in neoteny
during dendritic spine maturation [41]. Overview of
SRGAP2 paralogs is presented in Table 4. Haploid state of
ancestral SRGAP2 and diploid state of regulatory
SRGAP2C could potentially explain specific brain MRI
findings in our case, that is mainly significantly reduced
gyrification by two scenarios: I) SRGAP2C in normal dip-
loid state could hypothetically inhibit all ancestral
SRGAP2 expressions with functional consequence, so our
case could present a complete knockout phenotype. A
knockout mouse for ancestral SRGAP2 shows no ab-
normalities in cortical lamination, but neuronal mi-
gration is extremely fast. In our case the neurons are
probably spreading toward their destination either too
fast and/or too early or even could be misplaced due
to their inability to establish the right speed of neur-
onal migration (regulated by SRGAP2A-2C inter-
action). In either case the neurons might fail to form
stable or functional synapses leading to reduced gyri-
fication; II) It is also possible that specific brain MR
findings presented in our case are due to haploinsuffi-
ciency of only ancestral SRGAP2 (HI score 8.32),
regardless of SRGAP2A-2C interaction. Mouse knock-
down model for ancestral SRGAP2 displays significant
decrease in both axonal and dendritic branching with
accelerated radial migration – the characteristics that
could potentially explain reduced gyrification. How-
ever, only the postmortem brain analyses could verify
these hypotheses.
CD55 (CD55 molecule, decay accelerating factor for
complement, HGNC: 2665, 1q32) gene encodes glyco-
protein that has a physiological role to inhibit the
complement cascade, protecting autologous cells and
tissues from complement-mediated damage. It was re-
cently demonstrated that certain number of genes be-
longing to macrophages/immune system (including
Fig. 6 Literature overview of larger deletions which include additional genes outside of the IRF6 genomic region
Fig. 7 Four copies of SRGAP2 genes and duplication events
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Table 3 Short description on ancestral SRGAP2 function
Gene mRNA expression Protein expression Function Knockout Knockdown Overexpression
SRGAP2a ↑ Proliferative
zone (VZ and SVZ)
↑ Postmitotic
regions (CP)
↑ throughout cortical
development
culminating at P1
corresponding to the
peak of neuronal
migration in the
cortex
negatively regulate
the rate of radial
migration by
promoting LP
branching and
dynamics
stage 1
neurons:through its
F-BAR domain, induces
filopodia
stage 2 neurons:
↑ significantly
increased the total
number of primary
neurites emerging
from the cell body
↑ increase the number
of primary neurite
branches
mice are viable
(although born
significantly below
the expected
Mendelian ratio)
No abnormality in
cortical lamination
dendritic spine
morphology:
↑ neck length
↑ spine density
Juvenile: ↓ head
width
Adult: ↑ head width
↓ in cortical neurons
led to a significant
decrease in both axonal
and dendritic
branching
↑significant increase in
the percentage of
neurons that have
reached the dense CP
and a corresponding
decreased percentage
of neurons in the IZ
↑ accelerated radial
migration
↓ LP in layer 5/6 was
significantly less
branched and less
complex
dendritic spine
morphology:
↑ neck length
↑ spine density
Juvenile: ↓ head width
Adult: ↑ head width
significantly reduced
the number of cells
reaching the CP
↓severely inhibited
radial migration
↑increase in the
percentage of
neurons with
multiple processes
emerging from the
cell body – induce
excessive branching
of radially migrating
neurons
no transition from
multipolar cells to a
full LP (no cell body
translocation)
↑ spine heads
↓ spine neck
↑ enlargement of
dendritic spines
VZ ventricular zone
SVZ subventricular zone
CP cortical plate
LP leading process
IZ intermediate zone
aFunction of ancestral SRGAP2
Table 4 Short overview of SRGAP2 paralogs
Gene Estimated time of
duplication
Structure Mapping GRCh38/
hg38
Strand Expression in
human braina
Copy
number
Function
SRGAP2A protein sequence is
highly constrained (no
changes among non-
human primates, and
only a single amino-acid
change between human
and mouse orthologs)
22 exons;N-terminal F-BAR
domain – involved in membrane
deformation;central Rho-GAP domain
– specifically stimulates
GTPase activity of Rac1;C-terminal tail
with SH3 domain – interacts withF-BAR
domain = autoinhibition?
1q32.1 + ↑in the
germinal layers
and cortical
plate
2 controls
cortical
neural
migration
SRGPA2B ~3.4 million years promoter and 1–9 exons of ancestral
SRGAP23'-breakpoint located in intron
9 → truncatedF-BAR domainb
1q21.1 - ↓ 0-4 interacts
with
SRGAP2A
SRGAP2C ~2.4 million years duplication of SRGAP2B to 1p11.23'-
breakpoint located in intron 9 →
truncated F-BAR domainb
1p11.2 + ↑in the
germinal layers
(in culture
longer
maintains a
high level of
expression than
SRGAP2A)
2 inhibits
SRGAP2A -
SRGAP2
knockdown
SRGAP2D ~1 million years duplication of SRGAP2B and additional
deletion of exons 2 and 3 →
premature termination codonb
1p21.1 + ↓ 0-4 most likely
no function
– probably
subjected to
nonsense-
mediated
decay
afrom Cell. 2012;149(4):912–922 and Cell.2012;149(4):923–935
bparalogs have some additional variants
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CD55) show differential expression between ages of 3
to 6 months after birth (time of intense overshoot-
type synaptic formation – number of synapses reach
the peak, and pruning taking place after this peak)
[42]. The process of synaptic phagocytosis by micro-
glia which is occurring at the time of the overshoot-
type synaptic formations could cause damage to nor-
mal tissue and mitochondria. The fact that CD55
shows the higher expression at 6 months than at
3 months, may suggests that normal brain tissue is more
protected at 6 M [43]. The deletion of CD55 gene in our
case could have potential role in the “fine tuning” of syn-
aptic pruning in a negative way. Reduced level of the
glycoprotein, due to a deletion, could hypothetically make
normal brain tissue more prone to negative side effects of
phagocytosis during pruning period. Further functional
analysis could shed more light on this process and reveal
the neuro-protective genes.
TBL1XR1 (transducin (beta)-like 1 X-linked receptor 1,
HGNC:29529, 3q26.33) is essential in mediating transcrip-
tion silencing by unliganded nuclear receptors (NRs) and
other regulated transcription factors (TFs) [44–46].
Through the recruitment of the specific proteasome com-
plex, TBL1XR1 can act as a transcription activator which
mediates the exchange of corepressors for coactivators
[47, 48]. TBL1XR1 haploinsufficiency was so far described
in only three patients, all characterized by facial dys-
morphism, speech delay, mild to moderate cognitive def-
icit, and lack of autistic behaviors [49, 50]. Interestingly,
mutations in TBL1XR1 gene were recently identified in
three patients displaying ASD and severe ID, but without
any obvious dysmorphism or recurrent comorbidities
[51, 52]. HI score for TBL1XR1 is 6.81.
Conclusion
The deletion in our patient appeared to be a very
rare event and provides a valuable insight for
genotype-phenotype correlations in genetic disorders.
The phenotype in presented case points on the im-
portance of looking for the recessive disorders when
deletion is detected. The deletion might in turn un-
mask recessive disorder; even when the HI score is
low. Only by combining the GTG-banding, FISH and
CMA analyses we were able to fully characterize the
structural rearrangement within 1q. Brain MRI is
crucial for the patients with cognitive deficit, as it
allows better genotype-phenotype correlations and
understanding of gene aberration consequences.
Finally, the aberrations in SRGAP2 are strong candi-
dates underlying specific brain abnormalities, namely
reduced volume of grey matter and reduced gyrifica-
tion. Further analyses of the cases with SRGAP2
aberrations should be highly informative in this
respect.
Endnotes
1Haploinsufficiency score (HI score) of less than ten, indi-
cating that genes are dosage sensitive and expected to have
phenotypic effect. From https://decipher.sanger.ac.uk/
2All discussed genes are described and indexed in de-
tail in Additional file 1.
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